Sign in

Publications

Search in 13060 publications:

Reset RSS
Time frame
11579 Publication(s)
Feb 11, 2023
Efficacy of the Glucagon-Like Peptide-1 Receptor Agonists Liraglutide and Semaglutide for the Treatment of Weight Regain After Bariatric surgery: a Retrospective Observational Study.
Jensen A, Renström F, Aczel S, Folie P, Biraima M, Beuschlein F, Bilz S. Efficacy of the Glucagon-Like Peptide-1 Receptor Agonists Liraglutide and Semaglutide for the Treatment of Weight Regain After Bariatric surgery: a Retrospective Observational Study. Obes Surg 2023:1-9.
Feb 11, 2023
Efficacy of the Glucagon-Like Peptide-1 Receptor Agonists Liraglutide and Semaglutide for the Treatment of Weight Regain After Bariatric surgery: a Retrospective Observational Study.
Feb 11, 2023

Obes Surg 2023:1-9

Jensen Anders Boisen, Renström Frida, Aczel Stefan, Folie Patrick, Biraima Magdalena, Beuschlein Felix, Bilz Stefan

more
Feb 10, 2023
[Diagnosis and treatment of benign eyelid tumors].
Varde M, Heindl L, Kakkassery V. [Diagnosis and treatment of benign eyelid tumors]. Ophthalmologie 2023; 120:240-251.
Feb 10, 2023
[Diagnosis and treatment of benign eyelid tumors].
Feb 10, 2023

Ophthalmologie 2023; 120:240-251

Varde Meghana, Heindl L M, Kakkassery V

more
Feb 9, 2023
Fibroblast-expressed LRRC15 is a receptor for SARS-CoV-2 spike and controls antiviral and antifibrotic transcriptional programs.
Loo L, Waller M, Moreno C, Cole A, Stella A, Pop O, Jochum A, Ali O, Denes C, Hamoudi Z, Chung F, Aggarwal A, Low J, Patel K, Siddiquee R, Kang T, Mathivanan S, Mackay J, Jochum W, Flatz L, Hesselson D, Turville S, Neely G. Fibroblast-expressed LRRC15 is a receptor for SARS-CoV-2 spike and controls antiviral and antifibrotic transcriptional programs. PLoS Biol 2023; 21:e3001967.
Feb 9, 2023
Fibroblast-expressed LRRC15 is a receptor for SARS-CoV-2 spike and controls antiviral and antifibrotic transcriptional programs.
Feb 9, 2023

PLoS Biol 2023; 21:e3001967

Loo Lipin, Waller Matthew A, Moreno Cesar L, Cole Alexander J, Stella Alberto Ospina, Pop Oltin-Tiberiu, Jochum Ann-Kristin, Ali Omar Hasan, Denes Christopher E, Hamoudi Zina, Chung Felicity, Aggarwal Anupriya, Low Jason K K, Patel Karishma, Siddiquee Rezwan, Kang Taeyoung, Mathivanan Suresh, Mackay Joel P, Jochum Wolfram, Flatz Lukas, Hesselson Daniel, Turville Stuart G, Neely G Gregory

more
Feb 9, 2023
[Diagnosis and treatment of malignant eyelid tumors].
Gniesmer S, Sonntag S, Schiemenz C, Ranjbar M, Heindl L, Varde M, Emmert S, Grisanti S, Kakkassery V. [Diagnosis and treatment of malignant eyelid tumors]. Ophthalmologie 2023; 120:262-270.
Feb 9, 2023
[Diagnosis and treatment of malignant eyelid tumors].
Feb 9, 2023

Ophthalmologie 2023; 120:262-270

Gniesmer S, Sonntag S R, Schiemenz C, Ranjbar M, Heindl L M, Varde Meghana, Emmert S, Grisanti S, Kakkassery V

more
Feb 9, 2023
Cost-Effectiveness of Nivolumab Plus Ipilimumab for the First-Line Treatment of Intermediate/Poor-Risk Advanced and/or Metastatic Renal Cell Carcinoma in Switzerland.
Çakar E, Oniangue-Ndza C, Schneider R, Klijn S, Vogl U, Rothermundt C, May J. Cost-Effectiveness of Nivolumab Plus Ipilimumab for the First-Line Treatment of Intermediate/Poor-Risk Advanced and/or Metastatic Renal Cell Carcinoma in Switzerland. Pharmacoecon Open 2023
Feb 9, 2023
Cost-Effectiveness of Nivolumab Plus Ipilimumab for the First-Line Treatment of Intermediate/Poor-Risk Advanced and/or Metastatic Renal Cell Carcinoma in Switzerland.
Feb 9, 2023

Pharmacoecon Open 2023

Çakar Esra, Oniangue-Ndza César, Schneider Ralph P, Klijn Sven L, Vogl Ursula M, Rothermundt Christian, May Jessica R

more
Feb 8, 2023
Darolutamide Maintenance in Patients With Metastatic Castration-Resistant Prostate Cancer With Nonprogressive Disease After Taxane Treatment (SAKK 08/16).
Gillessen S, Procopio G, Hayoz S, Kremer E, Schwitter M, Caffo O, Lorente D, Pedrazzini A, Roubaud G, Nenan S, Omlin A, Buttigliero C, Delgado Mingorance J, González-Del-Alba A, Delgado M, Nolè F, Turco F, Mestre R, Ribi K, Cathomas R. Darolutamide Maintenance in Patients With Metastatic Castration-Resistant Prostate Cancer With Nonprogressive Disease After Taxane Treatment (SAKK 08/16). J Clin Oncol 2023; 41:3608-3615.
Feb 8, 2023
Darolutamide Maintenance in Patients With Metastatic Castration-Resistant Prostate Cancer With Nonprogressive Disease After Taxane Treatment (SAKK 08/16).
Feb 8, 2023

J Clin Oncol 2023; 41:3608-3615

Gillessen Silke, Procopio Giuseppe, Hayoz Stefanie, Kremer Eloïse, Schwitter Michael, Caffo Orazio, Lorente David, Pedrazzini Augusto, Roubaud Guilhem, Nenan Soazig, Omlin Aurelius, Buttigliero Consuelo, Delgado Mingorance Juan Ignacio, González-Del-Alba Aránzazu, Delgado Maria Teresa, Nolè Franco, Turco Fabio, Mestre Ricardo Pereira, Ribi Karin, Cathomas Richard

more
Feb 7, 2023
A novel cryopreservation and biobanking strategy to study lymphoid tissue stromal cells in human disease.
Brandstadter J, De Martin A, Lütge M, Ferreira A, Gaudette B, Stanossek Y, Wang S, Gonzalez M, Camiolo E, Wertheim G, Austin B, Allman D, Salim M, Fajgenbaum D, Aster J, Ludewig B, Maillard I. A novel cryopreservation and biobanking strategy to study lymphoid tissue stromal cells in human disease. bioRxiv 2023
Feb 7, 2023
A novel cryopreservation and biobanking strategy to study lymphoid tissue stromal cells in human disease.
Feb 7, 2023

bioRxiv 2023

Brandstadter Joshua D, De Martin Angelina, Lütge Mechthild, Ferreira Antonio, Gaudette Brian T, Stanossek Yves, Wang Shumei, Gonzalez Michael V, Camiolo Edward, Wertheim Gerald, Austin Bridget, Allman David, Salim M, Fajgenbaum David C, Aster Jon C, Ludewig Burkhard, Maillard Ivan

more
Feb 7, 2023
Targeting Ara h 2 with human-derived monoclonal antibodies prevents peanut-induced anaphylaxis in mice.
Paolucci M, Wuillemin N, Homère V, Bieli D, Köhli A, Ballmer-Weber B, Waeckerle-Men Y, Pengo N, Kündig T, Sonati T, Johansen P. Targeting Ara h 2 with human-derived monoclonal antibodies prevents peanut-induced anaphylaxis in mice. Allergy 2023; 78:1605-1614.
Feb 7, 2023
Targeting Ara h 2 with human-derived monoclonal antibodies prevents peanut-induced anaphylaxis in mice.
Feb 7, 2023

Allergy 2023; 78:1605-1614

Paolucci Marta, Wuillemin Natascha, Homère Valentine, Bieli Dimitri, Köhli Alice, Ballmer-Weber Barbara, Waeckerle-Men Ying, Pengo Niccolò, Kündig Thomas M, Sonati Tiziana, Johansen Pål

more
Feb 6, 2023
Benefit of Advanced 3D DSA and MRI/CT Fusion in Neurovascular Pathology.
Dobrocky T, Matzinger M, Piechowiak E, Kaesmacher J, Pilgram-Pastor S, Goldberg J, Bervini D, Klail T, Mendes Pereira V, Z'Graggen W, Raabe A, Mordasini P, Gralla J. Benefit of Advanced 3D DSA and MRI/CT Fusion in Neurovascular Pathology. Clin Neuroradiol 2023; 33:669-676.
Feb 6, 2023
Benefit of Advanced 3D DSA and MRI/CT Fusion in Neurovascular Pathology.
Feb 6, 2023

Clin Neuroradiol 2023; 33:669-676

Dobrocky Tomas, Matzinger Marco, Piechowiak Eike Immo, Kaesmacher Johannes, Pilgram-Pastor Sara M, Goldberg Johannes, Bervini David, Klail Tomas, Mendes Pereira Vitor, Z'Graggen Werner J, Raabe Andreas, Mordasini Pasquale, Gralla Jan

more
Feb 6, 2023
Myocardial Milieu Favors Local Differentiation of Regulatory T Cells.
Delgobo M, Weiß E, Ashour D, Richter L, Popiolkowski L, Arampatzi P, Stangl V, Arias-Loza P, Mariotti-Ferrandiz E, Rainer P, Saliba A, Ludewig B, Hofmann U, Frantz S, Ramos G. Myocardial Milieu Favors Local Differentiation of Regulatory T Cells. Circ Res 2023; 132:565-582.
Feb 6, 2023
Myocardial Milieu Favors Local Differentiation of Regulatory T Cells.
Feb 6, 2023

Circ Res 2023; 132:565-582

Delgobo Murilo, Weiß Emil, Ashour DiyaaElDin, Richter Leon, Popiolkowski Lisa, Arampatzi Panagiota, Stangl Verena, Arias-Loza Paula, Mariotti-Ferrandiz Encarnita, Rainer Peter P, Saliba Antoine-Emmanuel, Ludewig Burkhard, Hofmann Ulrich G, Frantz Stefan, Ramos Gustavo Campos

more
Feb 6, 2023
Ventral-inlay buccal mucosal graft urethroplasty in a 44-year old female patient with recurrent urethral stricture.
Burkhardt O, Schmid H, Engeler D, Zumstein V. Ventral-inlay buccal mucosal graft urethroplasty in a 44-year old female patient with recurrent urethral stricture. J Surg Case Rep 2023; 2023:rjad025.
Feb 6, 2023
Ventral-inlay buccal mucosal graft urethroplasty in a 44-year old female patient with recurrent urethral stricture.
Feb 6, 2023

J Surg Case Rep 2023; 2023:rjad025

Burkhardt Orlando, Schmid Hans-Peter, Engeler Daniel, Zumstein Valentin

more
Feb 6, 2023
Nursing Care For Patients With Cirrhosis.
Fabrellas N, Künzler-Heule P, Olofson A, Jack K, Carol M. Nursing Care For Patients With Cirrhosis. J Hepatol 2023
Feb 6, 2023
Nursing Care For Patients With Cirrhosis.
Feb 6, 2023

J Hepatol 2023

Fabrellas Núria, Künzler-Heule Patrizia, Olofson Amy, Jack Kathryn, Carol Marta

more
Feb 5, 2023
Estimated glomerular filtration rate, haemodynamics, and mortality in patients with aortic stenosis.
Appert S, Weber L, Breuss A, Haager P, Joerg L, Weilenmann D, Chronis J, Rigger J, Rickli H, Maeder M. Estimated glomerular filtration rate, haemodynamics, and mortality in patients with aortic stenosis. Eur J Clin Invest 2023:e13965.
Feb 5, 2023
Estimated glomerular filtration rate, haemodynamics, and mortality in patients with aortic stenosis.
Feb 5, 2023

Eur J Clin Invest 2023:e13965

Appert Sharon, Weber Lukas, Breuss Alexander, Haager Philipp K, Joerg Lucas, Weilenmann Daniel, Chronis Joannis, Rigger Johannes, Rickli Hans, Maeder Micha

more
Feb 4, 2023
Prognostic value of low heart rates in patients admitted with acute myocardial infarction.
Biasco L, Foster-Witassek F, Radovanovic D, Dittli P, Tersalvi G, Rickli H, Roffi M, Eberli F, Jeger R, Erne P, Pedrazzini G. Prognostic value of low heart rates in patients admitted with acute myocardial infarction. Rev Esp Cardiol (Engl Ed) 2023; 76:626-634.
Feb 4, 2023
Prognostic value of low heart rates in patients admitted with acute myocardial infarction.
Feb 4, 2023

Rev Esp Cardiol (Engl Ed) 2023; 76:626-634

Biasco Luigi, Foster-Witassek Fabienne, Radovanovic Dragana, Dittli Philip, Tersalvi Gregorio, Rickli Hans, Roffi Marco, Eberli Franz R, Jeger Raban V, Erne Paul, Pedrazzini Giovanni Battista

more
Feb 3, 2023
Efficacy and safety results by menopausal status in monarchE: adjuvant abemaciclib combined with endocrine therapy in patients with HR+, HER2-, node-positive, high-risk early breast cancer.
Paluch-Shimon S, Neven P, Huober J, Cicin I, Goetz M, Shimizu C, Huang C, Lueck H, Beith J, Tokunaga E, Contreras J, de Sant'Ana R, Wei R, Shahir A, Nabinger S, Forrester T, Johnston S, Harbeck N. Efficacy and safety results by menopausal status in monarchE: adjuvant abemaciclib combined with endocrine therapy in patients with HR+, HER2-, node-positive, high-risk early breast cancer. Ther Adv Med Oncol 2023; 15:17588359231151840.
Feb 3, 2023
Efficacy and safety results by menopausal status in monarchE: adjuvant abemaciclib combined with endocrine therapy in patients with HR+, HER2-, node-positive, high-risk early breast cancer.
Feb 3, 2023

Ther Adv Med Oncol 2023; 15:17588359231151840

Paluch-Shimon Shani, Neven Patrick, Huober Jens, Cicin Irfan, Goetz Matthew P, Shimizu Chikako, Huang Chiun-Sheng, Lueck Hans Joachim, Beith Jane, Tokunaga Eriko, Contreras Jessica Reyes, de Sant'Ana Rosane Oliveira, Wei Ran, Shahir Ashwin, Nabinger Sarah C, Forrester Tammy, Johnston Stephen R D, Harbeck Nadia

more
Feb 2, 2023
Endovascular Therapy or Medical Management Alone for Isolated Posterior Cerebral Artery Occlusion: A Multicenter Study.
Sabben C, Charbonneau F, Delvoye F, Strambo D, Heldner M, Ong E, Ter Schiphorst A, Hénon H, Ben Hassen W, Agasse-Lafont T, Legris L, Sibon I, Wolff V, Sablot D, Elhorany M, Preterre C, Nehme N, Soize S, Weisenburger-Lile D, Triquenot-Bagan A, Mione G, Aignatoaie A, Papassin J, Poll R, Béjot Y, Carrera E, Garnier P, Michel P, Saliou G, Mordasini P, Berthezene Y, Costalat V, Bricout N, Albers G, Mazighi M, Turc G, Seners P, ACAPULCO Collaborators. Endovascular Therapy or Medical Management Alone for Isolated Posterior Cerebral Artery Occlusion: A Multicenter Study. Stroke 2023; 54:928-937.
Feb 2, 2023
Endovascular Therapy or Medical Management Alone for Isolated Posterior Cerebral Artery Occlusion: A Multicenter Study.
Feb 2, 2023

Stroke 2023; 54:928-937

Sabben Candice, Charbonneau Frédérique, Delvoye François, Strambo Davide, Heldner Mirjam R, Ong Elodie, Ter Schiphorst Adrien, Hénon Hilde, Ben Hassen Wagih, Agasse-Lafont Thomas, Legris Loïc, Sibon Igor, Wolff Valérie, Sablot Denis, Elhorany Mahmoud, Preterre Cécile, Nehme Nour, Soize Sébastien, Weisenburger-Lile David, Triquenot-Bagan Aude, Mione Gioia, Aignatoaie Andreea, Papassin Jérémie, Poll Roxana, Béjot Yannick, Carrera Emmanuel, Garnier Pierre, Michel Patrik, Saliou Guillaume, Mordasini Pasquale, Berthezene Yves, Costalat Vincent, Bricout Nicolas, Albers Gregory W, Mazighi Mikaël, Turc Guillaume, Seners Pierre, ACAPULCO Collaborators

more
Feb 2, 2023
European Stroke Organisation (ESO) expedited recommendation on tenecteplase for acute ischaemic stroke.
Alamowitch S, Turc G, Palaiodimou L, Bivard A, Cameron A, De Marchis G, Fromm A, Kõrv J, Roaldsen M, Katsanos A, Tsivgoulis G. European Stroke Organisation (ESO) expedited recommendation on tenecteplase for acute ischaemic stroke. Eur Stroke J 2023; 8:8-54.
Feb 2, 2023
European Stroke Organisation (ESO) expedited recommendation on tenecteplase for acute ischaemic stroke.
Feb 2, 2023

Eur Stroke J 2023; 8:8-54

Alamowitch Sonia, Turc Guillaume, Palaiodimou Lina, Bivard Andrew, Cameron Alan, De Marchis Gian Marco, Fromm Annette, Kõrv Janika, Roaldsen Melinda B, Katsanos Aristeidis H, Tsivgoulis Georgios

more
Feb 2, 2023
Prospective Assessment of Cerebral Microbleeds with Low-Field Magnetic Resonance Imaging (0.55 Tesla MRI).
Rusche T, Breit H, Bach M, Wasserthal J, Gehweiler J, Manneck S, Lieb J, De Marchis G, Psychogios M, Sporns P. Prospective Assessment of Cerebral Microbleeds with Low-Field Magnetic Resonance Imaging (0.55 Tesla MRI). J Clin Med 2023; 12
Feb 2, 2023
Prospective Assessment of Cerebral Microbleeds with Low-Field Magnetic Resonance Imaging (0.55 Tesla MRI).
Feb 2, 2023

J Clin Med 2023; 12

Rusche Thilo, Breit Hanns-Christian, Bach Michael, Wasserthal Jakob, Gehweiler Julian, Manneck Sebastian, Lieb Johanna M, De Marchis Gian Marco, Psychogios Marios-Nikos, Sporns Peter B

more
Feb 2, 2023
Reset of Inflammatory Priming of Joint Tissue and Reduction of the Severity of Arthritis Flares by Bromodomain Inhibition.
Friščić J, Reinwald C, Böttcher M, Houtman M, Euler M, Chen X, Walker K, Kirchner P, Zhu H, Wirth B, Weidner D, Krüger R, Trajkovic V, Ekici A, Klein K, Mougiakakos D, Ospelt C, Schett G, Hoffmann M. Reset of Inflammatory Priming of Joint Tissue and Reduction of the Severity of Arthritis Flares by Bromodomain Inhibition. Arthritis Rheumatol 2023; 75:517-532.
Feb 2, 2023
Reset of Inflammatory Priming of Joint Tissue and Reduction of the Severity of Arthritis Flares by Bromodomain Inhibition.
Feb 2, 2023

Arthritis Rheumatol 2023; 75:517-532

Friščić Jasna, Reinwald Christiane, Böttcher Martin, Houtman Miranda, Euler Maximilien, Chen Xiang, Walker Kellie I, Kirchner Philipp, Zhu Honglin, Wirth Benjamin, Weidner Daniela, Krüger René, Trajkovic Vladimir, Ekici Arif B, Klein Kerstin, Mougiakakos Dimitrios, Ospelt Caroline, Schett Georg, Hoffmann Markus H

more
Feb 2, 2023
Partially reversible lung consolidation after revascularization of a total occlusion of both left pulmonary veins following ablation of atrial fibrillation: a case report.
Ahero A, Frauenfelder T, Breitenstein A, Ammann P, Kucher N, Barco S. Partially reversible lung consolidation after revascularization of a total occlusion of both left pulmonary veins following ablation of atrial fibrillation: a case report. Eur Heart J Case Rep 2023; 7:ytad057.
Feb 2, 2023
Partially reversible lung consolidation after revascularization of a total occlusion of both left pulmonary veins following ablation of atrial fibrillation: a case report.
Feb 2, 2023

Eur Heart J Case Rep 2023; 7:ytad057

Ahero Anete, Frauenfelder Thomas, Breitenstein Alexander, Ammann Peter, Kucher Nils, Barco Stefano

more

We use cookies and tracking technologies according to our privacy policy to provide you with the best possible web experience. To the privacy policy